Sinobiopharma

Background

Established with investment from Joy Glory Limited (Hong Kong), Sinobiopharma is a modern innovative drug manufacturer built to high-tech enterprise standards. In collaboration with renowned institutions such as Nanjing University and China Pharmaceutical University, the company has built a robust high-tech R&D platform.

Sinobiopharma holds patented technologies in drug synthesis and novel dosage form development, focusing on the R&D and production of high-end generic and innovative drugs in cardiovascular, endocrine, and oncology therapeutic areas, maintaining a leading position in China.

Case details

• Total Investment: USD 60 million

• Registered Capital: USD 25 million

• Site Area: 24,000 m²

• Construction Area: 16,000 m²